Losappio, V.; Barbara, I.; Maiorano, A.; Simiele, S.; Rosato, S.; Mercuri, S.; Troise, D.; Stallone, G.; Pontrelli, P. Pentraxin 3 in Kidney Disease and Renal Replacement Therapies. Preprints2023, 2023051680. https://doi.org/10.20944/preprints202305.1680.v1
APA Style
Losappio, V., Barbara, I., Maiorano, A., Simiele, S., Rosato, S., Mercuri, S., Troise, D., Stallone, G., & Pontrelli, P. (2023). Pentraxin 3 in Kidney Disease and Renal Replacement Therapies. Preprints. https://doi.org/10.20944/preprints202305.1680.v1
Chicago/Turabian Style
Losappio, V., Giovanni Stallone and Paola Pontrelli. 2023 "Pentraxin 3 in Kidney Disease and Renal Replacement Therapies" Preprints. https://doi.org/10.20944/preprints202305.1680.v1
Abstract
Chronic kidney disease (CKD) is actually considered a public health priority according to the increasing number of patients affected by this condition: this casuistry is not only related to specific glomerular, tubular or autoimmune diseases or a consequence of acute kidney injury (AKI) episodes leading to organ failure, but it is tied to the progression of life expectancy and the impact of comorbidities such as cardiovascular disease, diabetes and cancer. CKD and its comorbidities promote low grade inflammatory status with an impact on patients’ clinical conditions, reducing their possibility for kidney transplantation or graft survival and their survival when receiving renal replacement therapies such as hemodialysis (HD) or peritoneal dialysis (PD). CKD is often referred to as an ageing accelerator: innate immune system dysregulation, in the uraemic proinflammatory milieu, is involved in this accelerated senescence phenomena and pentraxins, particularly Pentraxin-3 (PTX-3), are of particular interest in the development of kidney disease. A complete understanding of the mechanism of CKD progression, innate immune system involvement and a proper definition of PTX-3 role in kidney disease, could redefine the approach for diagnosis and a more centered patients’ management to slow down CKD progression over time and reduce its clinical and social impact.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
